FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Preferred Pharmaceuticals Losartan Potassium Tablets Recall

Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-…

Preferred Pharmaceuticals, Inc · Anaheim, CA

Risk level
Class II
Reported by FDA
Mar 27, 2019
Recall ID
D-1051-2019
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Losartan Potassium Tablets starting Mar 6, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1051-2019 on Mar 27, 2019. Reason: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified. Status: Terminated.

Why it was recalled

CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.

Product description

Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09), Rx Only, Mfg: Torrent Pharma Inc. Basking Ridge, NJ. Relabeled by: Preferred Pharmaceuticals, Inc. 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807.

Lot numbers, UPCs & expiration codes

Count, lots, expiry: a) 30-count bottle C2218C, exp 9/2020, D1318E, exp 10/2020; b) 90-count bottle C2719J, exp 9/2020, E1818B, exp 10/2020.

Where it was sold

California, Georgia, Indiana

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1051-2019
Classification
Class II
Status
Terminated
Recall initiated
Mar 6, 2019
FDA report date
Mar 27, 2019
Quantity
530
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc

Original FDA data

Every field from FDA enforcement report D-1051-2019, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Terminated
Country
United States
Event ID
82335
Address
1250 N Lakeview Ave Ste O
Code information
Count, lots, expiry: a) 30-count bottle C2218C, exp 9/2020, D1318E, exp 10/2020; b) 90-count bottle C2719J, exp 9/2020, E1818B, exp 10/2020.
Postal code
92807-1801
Report date
Mar 27, 2019
Product type
Drugs
Recall number
D-1051-2019
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc
Product quantity
530
Termination date
Mar 30, 2023
Reason for recall
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC: 68788-0048-09), Rx Only, Mfg: Torrent Pharma Inc. Basking Ridge, NJ. Relabeled by: Preferred Pharmaceuticals, Inc. 1250 N. Lakeview Ave., Suite O, Anaheim, CA 92807.
Distribution pattern
California, Georgia, Indiana
Recall initiation date
Mar 6, 2019
Initial firm notification
Telephone
Center classification date
Mar 21, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1051-2019, published Mar 27, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls